In today's world, LASSBio-881 has become a topic of great relevance and interest to a wide spectrum of society. Since its emergence, LASSBio-881 has captured the attention of academics, researchers, professionals and the general public due to its significant impact in various areas. Over time, LASSBio-881 has evolved and has generated endless debates, analyzes and reflections that seek to understand its implications and consequences. In this article, we will thoroughly explore the phenomenon of LASSBio-881, examining its many facets and delving into its importance in the current context.
![]() | |
Identifiers | |
---|---|
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C23H27N3O6 |
Molar mass | 441.484 g·mol−1 |
3D model (JSmol) | |
| |
|
LASSBio-881 is a drug which acts as both a non-selective partial agonist of the CB1 and CB2 cannabinoid receptors, and also as an antagonist of the TRPV1 receptor, as well as having antioxidant effects. It has potent anti-inflammatory and anti-hyperalgesic effects in animal studies.